Genomma Lab Internacional... (GNMLF)

PNK: GNMLF · Real-Time Price · USD

1.24

0.00 (0.00%)

At close: Apr 30, 2025, 2:49 PM

Genomma Lab Internacional S.A.B. de C.V. Income Statement

Financials in MXN. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	14.42B	10.26B	5.81B	966.43M	967.8M	946.18M	952.51M	916.19M	875.93M	846.19M	831.49M	808.7M	788.12M	759.61M	560.45M	367.53M	173.39M
Cost of Revenue	5.27B	3.72B	2.08B	357.1M	365.36M	366.91M	375.39M	363.17M	348.61M	334.62M	316.69M	308.22M	299.31M	290.61M	216.89M	142.85M	66.82M
Gross Profit	9.14B	6.54B	3.72B	609.32M	602.44M	579.27M	577.12M	553.02M	527.32M	511.57M	514.8M	500.47M	488.82M	469M	343.56M	224.68M	106.57M
Operating Income	3.26B	2.36B	1.39B	308.83M	194.32M	184.58M	186.32M	175.93M	169.72M	163.75M	158.66M	153.39M	149.08M	146.8M	106.54M	70.94M	33.62M
Interest Income	99.4M	106.11M	69.31M	49.72M	44.39M	11.32M	13.18M	9.52M	7.36M	5.94M	6.02M	4.95M	3.5M	3.18M	1.25M	221.11K	164.81K
Pretax Income	2.28B	1.61B	1.02B	118.83M	106.62M	99.73M	119.83M	115.57M	113.68M	112.23M	119.24M	117.76M	112.57M	113.35M	81.92M	53.91M	27.25M
Net Income	1.04B	563.88M	83.59M	71.35M	61.27M	58.66M	78.47M	77M	72.75M	69.96M	67.48M	66.72M	65.66M	64.22M	53.7M	34.66M	15.61M
Selling & General & Admin	5.75B	4.15B	2.39B	409.58M	408.12M	394.69M	390.79M	377.09M	357.6M	347.83M	356.14M	347.08M	339.73M	322.2M	237.02M	153.74M	72.95M
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	234.4M	150.17M	63.06M	1.45M	1.8M	48.5M	48.5M	48.5M	48.5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	5.99B	4.29B	2.45B	409.58M	408.12M	394.69M	390.79M	377.09M	357.6M	347.83M	356.14M	347.08M	339.73M	322.2M	237.02M	153.74M	72.95M
Interest Expense	907.28M	887.8M	654.67M	442.15M	245.36M	56.15M	53.16M	48.36M	46.55M	46.84M	44.41M	43.93M	41.95M	37.88M	28.07M	15.61M	7.62M
Selling & Marketing Expenses	72.8M	-1.62B	-3.04B	-4.73B	-6.49B	-6.44B	-6.59B	-4.84B	-3.15B	-1.51B	59.8M	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	11.15B	7.91B	4.42B	657.6M	773.48M	761.59M	766.19M	740.26M	706.21M	682.44M	672.83M	655.31M	639.04M	612.81M	453.92M	296.59M	139.77M
Income Tax Expense	565.87M	372.16M	257.46M	-4.54M	39.08M	37.72M	41.18M	41.65M	42.84M	43.48M	43.51M	41.93M	39.97M	44.76M	30.31M	21.23M	12.81M
Shares Outstanding (Basic)	973.79M	944.86M	944.93M	945.14M	945.14M	954.58M	954.58M	957.46M	961.99M	975.35M	998.19M	999.57M	1.01B	1B	1.01B	1.01B	1.01B
Shares Outstanding (Diluted)	973.79M	977.75M	944.93M	945.14M	945.14M	954.58M	954.58M	957.46M	961.99M	975.35M	998.19M	999.57M	1.01B	1B	1.01B	1.01B	1.01B
EPS (Basic)	1.06	0.58	0.09	0.08	0.06	0.06	0.08	0.08	0.07	0.07	0.07	0.07	0.07	0.06	0.05	0.03	0.02
EPS (Diluted)	1.08	0.60	0.09	0.08	0.06	0.06	0.08	0.08	0.07	0.07	0.07	0.07	0.07	0.06	0.05	0.03	0.02
EBITDA	3.4B	2.44B	1.51B	309.95M	194.52M	180.6M	188.83M	179.4M	172.44M	168.04M	797.93M	790.06M	784.74M	781.56M	112.1M	74.68M	35.54M
EBIT	2.99B	2.12B	1.3B	187.74M	922.92M	913.65M	923.77M	914.72M	858.36M	857.2M	863.23M	1.57B	1.46B	1.46B	1.42B	665.49M	34.87M
Depreciation & Amortization	311.24M	219.65M	103.24M	18.17M	17.25M	15.62M	13.72M	13.13M	12.39M	11.4M	11.3M	10.25M	9.25M	8.34M	5.56M	3.74M	1.92M